News

Reference payment plan cuts colonoscopy costs by 20%

View on the News

Quality of lower-priced care

Robinson et al. interpreted the steady complication rate throughout their study to be an indicator that the quality of colonoscopies didn’t decline when patients switched to less-expensive providers. However, they were unable to assess other important measures of quality, such as the adenoma detection rate. Such assessments are needed to ensure that patients who choose lower-priced practices still receive high-quality care.

David Lieberman, M.D., is in the division of gastroenterology and hepatology at Oregon Health and Science University, Portland. John Allen, M.D., AGAF, is at Yale University, New Haven, Conn. Dr. Lieberman reported serving on scientific advisory boards for Given Imaging, Ironwood Pharmaceuticals, Exact Sciences, and Motus GI. Dr. Allen reported serving as a consultant for Olympus, gMed, and Pentax. Dr. Lieberman and Dr. Allen made these remarks in a commentary (JAMA Intern Med. 2015 Sep 8 [doi:101001/jamainternmed.2015.4594]).


 

FROM JAMA INTERNAL MEDICINE

References

When a large state employer – California’s public employee system – switched to “reference payment” health insurance coverage of colonoscopy, patients shifted toward using lower-priced facilities and the price of the procedure dropped by 20%, according to a report published online Sept. 8 in JAMA Internal Medicine.

This reference payment plan provided full coverage for colonoscopy up to the reference payment limit of $1,500, requiring patients to pay the difference between this limit and the price they were actually charged if they chose a higher-priced facility. The $1,500 limit was set at the 80th percentile of the range of prices charged by all ambulatory surgical centers in the region; most hospital-based colonoscopy facilities charged more, said James C. Robinson, Ph.D., of the University of California-Berkeley School of Public Health.

Dr. James C. Robinson

Dr. James C. Robinson

He and his coinvestigators analyzed insurance claims data, comparing the costs of 21,644 colonoscopies performed during the 3 years preceding this type of coverage with those of 13,551 colonoscopies performed during the 2 years after reference payment coverage was implemented. They compared these findings with those for a control group: 258,616 people covered by a standard health insurance plan that remained the same during the 5-year study period.

During the earlier period, 69% of state enrollees underwent colonoscopies at the less-expensive ambulatory centers, while the remaining 31% had them at more expensive hospital-based outpatient departments. After reference payment was implemented, the proportion of enrollees who chose the less expensive option rose to 86% the first year and to 90% the second year. In comparison, the control group’s use of ambulatory centers remained steady at 71%-74% throughout the study period.

After the reference payment plan was implemented, the mean price paid per colonoscopy decreased by 20.3% in the first year and 21.0% the second year among the state employees, while it rose in the control group. With reference payment, each colonoscopy cost $476 less the first year and $576 less the second year than with standard health insurance, Dr. Robinson and his associates said (JAMA Intern. Med. 2015 Sep 8. doi:10.1001/jamainternmed.2015.4588).

At the same time that prices dropped, there were no significant changes in complication rates, suggesting that the quality of care did not suffer. The incidence of serious gastrointestinal complications (including perforation, lower GI bleeding, and infection), other gastrointestinal complications (such as paralytic ileus, nausea, vomiting, dehydration, pain, diverticulitis, and enterocolitis), and cardiovascular complications (arrhythmia, congestive heart failure, cardiac or respiratory arrest, syncope, hypotension, and shock) remained steady throughout the study period.

During the first 2 years after implementation of the reference payment system, the state public employee system saved approximately $7.0 million, or 28%, compared with what it would have spent on colonoscopy without that system, the investigators noted.

Recommended Reading

Circulating tumor DNA marked progressive liver cancer
MDedge Internal Medicine
Gluten exposure tied to worsened GI and extraintestinal symptoms in gluten sensitivity
MDedge Internal Medicine
Assessing progression, impact of radiofrequency ablation in Barrett’s esophagus
MDedge Internal Medicine
H. pylori resistance highlights need for guided therapy
MDedge Internal Medicine
Subclinical heart dysfunction, fatty liver linked
MDedge Internal Medicine
Celiac disease ‘as common as psoriasis’
MDedge Internal Medicine
ESC: Celecoxib safety study may soothe cardio concerns
MDedge Internal Medicine
Virologic response no protection against HCV liver decompensation
MDedge Internal Medicine
VIDEO: Does childhood abdominal pain portend adult GI problems?
MDedge Internal Medicine
Hepatitis E linked to 1 in 10 liver failure cases in Europe
MDedge Internal Medicine